VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ASND
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ASNDAscendis Pharma A/S
$266.97$16.5B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksASNDQuarterly Financials

Ascendis Pharma A/S (ASND) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Ascendis Pharma A/S (ASND) quarterly income statement — complete revenue, gross profit & net income history

ASND Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue250.66M245.18M213.63M158.04M100.95M173.92M57.83M36M95.89M137.7M48.03M47.39M33.59M22.9M15.29M6.16M6.83M4.9M1.11M1.02M
Revenue Growth %148.29%40.98%269.4%339.04%5.28%26.3%20.4%-24.04%185.49%501.42%214.15%669.37%391.93%367.55%1273.76%502.74%815.28%815.33%-59.63%-28.83%
Cost of Goods Sold21.62M27.2M22.35M31.45M17.52M14.02M11.2M11.46M7.57M19.46M7.39M12.93M4.62M5.11M1.69M1.09M4.25M3.52M00
COGS % of Revenue8.63%11.09%10.46%19.9%17.35%8.06%19.37%31.85%7.89%14.13%15.38%27.28%13.76%22.33%11.07%17.63%62.19%71.94%--
Gross Profit229.03M217.98M191.28M126.6M83.44M159.89M46.63M24.53M88.33M118.25M40.65M34.46M28.97M17.78M13.6M5.07M2.58M1.37M1.11M1.02M
Gross Margin %91.37%88.91%89.54%80.1%82.65%91.94%80.63%68.15%92.11%85.87%84.62%72.72%86.24%77.67%88.93%82.37%37.81%28.06%100%100%
Gross Profit Growth %174.5%36.33%310.19%416.03%-5.53%35.22%14.73%-28.82%204.91%564.9%198.93%579.23%1021.92%1194.32%1121.65%396.48%246.11%100.74%101.82%101.64%
Operating Expenses203.81M208.18M180.28M179.55M187.65M159.51M143.38M157.79M137.47M154.86M175.05M175.3M172.65M165.17M158.1M146.97M130.61M113.95M98.05M118.65M
OpEx % of Revenue81.31%84.91%84.39%113.61%185.88%91.72%247.91%438.33%143.36%112.46%364.44%369.89%514.02%721.39%1034.02%2385.83%1912.87%2327.04%8809.07%11609.69%
Selling, General & Admin146.18M133.2M111.69M105.71M95.65M78.78M68.13M74.31M66.78M63.98M62.51M70.28M66.54M56.55M60.67M56.58M47.42M48.3M39.28M35.34M
SG&A % of Revenue58.32%54.33%52.28%66.89%94.74%45.3%117.8%206.43%69.64%46.46%130.14%148.29%198.1%247%396.8%918.57%694.46%986.4%3529.56%3458.41%
Research & Development57.63M74.98M66.88M71.99M86.6M79.3M73.54M83.48M70.69M90.88M111.44M105.02M106.11M108.62M97.43M90.38M83.19M65.65M58.76M83.31M
R&D % of Revenue22.99%30.58%31.31%45.55%85.78%45.59%127.17%231.9%73.71%66%232%221.6%315.92%474.4%637.22%1467.26%1218.41%1340.64%5279.51%8151.27%
Other Operating Expenses001000K1000K1000K1000K1000K0001000K000000000
Operating Income25.22M9.8M11M-52.95M-104.21M383K-96.74M-133.26M-49.15M-36.61M-134.41M-140.84M-143.69M-147.39M-144.5M-141.89M-128.03M-112.58M-96.93M-117.63M
Operating Margin %10.06%4%5.15%-33.5%-103.23%0.22%-167.28%-370.18%-51.25%-26.59%-279.82%-297.17%-427.77%-643.72%-945.09%-2303.46%-1875.06%-2298.98%-8709.07%-11509.69%
Operating Income Growth %124.2%2459.58%111.37%60.26%-112.05%101.05%28.02%5.38%65.8%75.16%6.99%0.74%-12.23%-30.92%-49.08%-20.63%-2.71%-17.71%-22.97%-41.81%
EBITDA29.51M14.58M15.02M-48.64M-99.67M4.86M-95.04M-131.24M-44.64M-31.76M-129.53M-136.2M-139.14M-145.94M-139.87M-137.43M-123.55M-108.28M-93.08M-113.95M
EBITDA Margin %11.77%5.95%7.03%-30.78%-98.73%2.79%-164.34%-364.58%-46.55%-23.07%-269.65%-287.39%-414.24%-637.41%-914.76%-2231.07%-1809.51%-2211.21%-8363.09%-11149.59%
EBITDA Growth %129.61%200.16%115.8%62.94%-123.26%115.3%26.62%3.64%67.92%78.24%7.39%0.9%-12.61%-34.78%-50.26%-20.61%-2.24%-16.86%-21.59%-41.12%
D&A (Non-Cash Add-back)4.29M4.78M4.02M4.31M4.54M4.47M1.7M2.02M4.5M4.85M4.88M4.63M4.55M1.44M4.64M4.46M4.48M4.3M3.85M3.68M
EBIT25.22M9.8M-57.37M-1.99M-48.78M-42.37M-72.83M-89.53M-51.37M-72.66M-137.06M-112.53M-107.83M-147.39M-144.5M-141.89M-119.86M-104.84M-79.47M-122.3M
Net Interest Income-63.77M-37.57M-16.39M22.04M-15.93M-9.92M2.93M29.43M-73.59M-68.55M-20.38M26.43M35.3M-71.67M-20.92M61.69M7.64M-45.23M20.44M-12M
Interest Income4.59M23.83M3.33M55.06M28.85M-66.55M28.28M49.05M3.58M04.14M35.76M45.13M020.33M71.13M13.04M021.32M145K
Interest Expense68.36M61.4M19.72M33.02M44.79M-56.63M25.35M19.62M77.16M68.55M24.52M9.33M9.84M71.67M41.25M9.43M5.4M45.23M877K12.14M
Other Income/Expense-74.19M-36.26M-68.37M17.94M10.65M-37.77M-1.44M24.11M-79.38M-44.48M-27.17M18.98M34.07M-54.68M-24.62M60.53M2.77M6.41M16.59M-16.81M
Pretax Income-48.97M-26.45M-57.37M-35.01M-93.56M-37.38M-98.18M-109.15M-128.53M-81.09M-161.58M-121.86M-109.62M-202.07M-169.12M-81.37M-125.26M-106.18M-80.34M-134.44M
Pretax Margin %-19.54%-10.79%-26.86%-22.15%-92.68%-21.5%-169.76%-303.21%-134.03%-58.89%-336.38%-257.13%-326.35%-882.55%-1106.1%-1320.88%-1834.46%-2168.18%-7218.6%-13154.79%
Income Tax-688.66M6.79M3.62M3.85M1.06M1.08M1.02M229K2.51M5.79M645K-429K1.3M5.35M-167K-47K241K-114K5K-68K
Effective Tax Rate %1406.31%-25.68%-6.3%-10.99%-1.13%-2.9%-1.04%-0.21%-1.95%-7.14%-0.4%0.35%-1.18%-2.65%0.1%0.06%-0.19%0.11%-0.01%0.05%
Net Income639.69M-33.25M-60.99M-38.85M-94.63M-38.47M-99.2M-109.38M-131.03M-86.88M-162.22M-121.43M-110.91M-207.42M-168.96M-81.32M-125.5M-106.06M-80.35M-134.37M
Net Margin %255.21%-13.56%-28.55%-24.58%-93.73%-22.12%-171.52%-303.85%-136.65%-63.09%-337.73%-256.23%-330.21%-905.91%-1105%-1320.11%-1837.99%-2165.86%-7219.05%-13148.14%
Net Income Growth %776.02%13.57%38.52%64.48%27.79%55.72%38.85%9.93%-18.14%58.11%3.98%-49.33%11.62%-95.56%-110.28%39.48%-99.86%23.68%34%-41.55%
Net Income (Continuing)639.69M-33.25M-60.99M-38.85M-94.63M-38.47M-99.2M-109.38M-131.03M-86.88M-162.22M-121.43M-110.91M-207.42M-168.96M-81.32M-125.5M-106.06M-80.35M-134.37M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)9.91-0.54-1.00-0.82-1.58-0.64-1.69-1.91-2.30-1.53-2.88-2.16-1.98-3.70-3.03-1.46-2.21-1.97-1.47-2.50
EPS Growth %727.22%15.63%40.83%57.07%31.3%58.17%41.32%11.57%-16.16%58.65%4.95%-47.95%10.41%-87.82%-106.12%41.6%-88.89%23.64%36.36%-26.9%
EPS (Basic)10.37-0.54-1.00-0.64-1.58-0.64-1.69-1.91-2.30-1.53-2.88-2.16-1.98-3.70-3.03-1.46-2.21-1.97-1.47-2.50
Diluted Shares Outstanding64.52M61.38M60.99M63.91M60.02M59.79M58.57M57.35M56.88M56.61M56.27M56.22M56.09M55.99M55.83M55.81M56.72M53.85M54.64M53.85M
Basic Shares Outstanding61.68M61.38M60.99M60.45M60.02M59.79M58.57M57.35M56.88M56.61M56.27M56.22M56.09M55.99M55.83M55.81M56.72M53.85M54.64M53.85M
Dividend Payout Ratio--------------------